Point of Care Diagnostics Market

The report "Point of Care Diagnostics Market by Product (Glucose, HIV, Hep C, HPV, Hematology, Pregnancy), Platform (Microfluidic, Dipstick, RT-PCR, INAAT), Sample(Blood, Urine), Purchase (OTC, Rx), End User (Pharmacy, Hospitals, Home Care) - Global Forecast to 2028" global point-of-care diagnostics market is expected to reach USD 77.8 billion by 2028 from an estimated USD 49.7 billion in 2023, at a CAGR of 9.4% from 2023 to 2028.

Browse 191 market data Tables and 51 Figures spread through 322 Pages and in-depth TOC on "Point of Care Diagnostics Market by Product (Glucose, HIV, Hep C, HPV, Hematology, Pregnancy), Platform (Microfluidic, Dipstick, RT-PCR, INAAT), Sample(Blood, Urine), Purchase (OTC, Rx), End User (Pharmacy, Hospitals, Home Care) - Global Forecast to 2028"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic-market-106829185.html

Globally, the growing burden of chronic diseases like diabetes, cardiovascular diseases, cancer is accelerating the demand for  rapid and effective daignostic testing.Moreover, the rising advancements in microfluidic technology, and miniaturization are eneabling manufacturers to develop portable and smaller PoC diagnostics devces. Moreover, the  shift  towards helathacre decentralization and increasing investments for product development is anticipated to bolster the growth opportunity for point of care daignostics market.

Pricing pressure due to reimbursement cuts and limited budgests along with strict regulatory approval process for new point of care product commercialization are factors expected to restrain market growth during the forecast period.

The Lateral Flow Assays segment segment, by platform , is expected to register the largest market share of the global point of care diagnostics market in 2022.

Based on platform, the point-of-care diagnostics market is segmented into lateral flow assays, immunoassays, microfluidics, dipsticks, and molecular diagnostics. The lateral flow assays segment dominated this market with a share of in 2022.Lateral flow assays are simpe in usage, relatively inexpensive, making it more accessible for patients and helathcare provider, LFA  technology does not requre trained person to operate , allowing  them to be used in various healthcare settings, from clinics and pharmacies to  remote arears, promoting halthcare decentralization. All these factors are contributing towards the dominace  of lateral flow technology in point of care diagnostics market.

The OTC testing product  segment , by mode of purchase, to dominate the  global point of care diagnostics market in 2022.

On the basis of mode of purchase OTC tetsing products segment acoounted the largets market share in 2022 attribuite ti the  increasing adoption of OTC products owing to its ease of usage  and convenience.The presence of diverse range of OTC point of care devices for diseases screening, personal helath monitoring  and various other conitions further contibutes to the rising demand for OTC PoC testing devices amoung consumers.

“The APAC market, by region, to register highest growth rate in the forecast period.”

On the basis of region, the radiotherapy  market is segmented into North America, Europe, Asia Pacific, and the Latin America, Middle East & Africa.  The Asia-Pacific market is likely to witness significant growth  owing to increase in cardiac diseases, diabetes, and infectious diseases  patient pool, moreover improving healthcare infrastructure and the implementation of supportive government initiatives to increase the accessibility of effective diagnostic tools  in several APAC countries such as India and China. The growing adoption of self testsing kits,  expansion of geographical footprints of key players, and emergence of many local players in the region are likely to support  growth of point of care diagnostics market in Asia Pacific

As of 2022, the point of care diagnostics  market was dominated by Abbott Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), and Becton, Dickinson and Company (US)

Don’t miss out on business opportunities in Point of Care Diagnostics Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]